Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the bioequivalence of a potential generic
6-mercaptopurine 50 mg tablet formulation compared with GlaxoSmithKline Purinethol®
(mercaptopurine) 50-mg scored tablets following a single 50 mg oral dose administered in the
fasted state.